CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

ConferenceDarovasertibIDE849Positive
AI Analysis

Summary

IDEAYA Biosciences announced three abstract presentations for its darovasertib and IDE849 clinical programs at the 2026 ESMO meeting in October.

Importance:4/10
Sentiment:
0.30
conference presentationoncologyprecision medicineESMO 2026
Related Companies

Read the original article

Published by PR Newswire Biotech on July 17, 2026 1:00 PM

Read Original